Type 2 diabetes Nutritional, Metabolic, Endocrine
Conditions
Interventions
The intervention will include two main components:
1. Modified Chinese version of Diabetes Education Toolkit, a set of plain-language tools to aid provider-patient communication about
Sponsors
China Medical Board (CMB) (USA)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patient has a clinical diagnosis of type 2 diabetes 2. Age 18-85 years 3. Most recent HbA1c >=7.5% 4. Patient agrees to participate in the study for the full two years duration
Exclusion criteria
Exclusion criteria: 1. Poor visual acuity (vision worse than 20/50 using Rosenbaum Pocket Screener) 2. Significant dementia, or psychosis (by health provider report or chart review) 3. Terminal illness with anticipated life expectancy < 2 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome will be changes in HbA1c at baseline and at 3, 6, 12, and 24 months of intervention. HbA1c level will be measured by a blood test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Other measures include self-care behaviors, blood pressure, cholesterol, and utilization of clinical services. Incremental costs per behavioral, biologic and QALY change will also be determined. This will be measured at baseline and at 3, 6, 12, and 24 months of intervention. | — |
Countries
China
Outcome results
None listed